Skip to main content
Premium Trial:

Request an Annual Quote

Genomed to Offer BGI's NIPT in Poland

NEW YORK (GenomeWeb) – BGI Europe and molecular diagnostics firm Genomed this week announced a partnership to offer BGI's non-invasive prenatal test in Poland.

The deal makes Genomed Poland's leading service provider of the test called NIFTY, the firms said. NIFTY detects the risk of certain genetic conditions, including Down syndrome, from as early as 10 weeks into the pregnancy.

The agreement, they said, advances the development of personalized medicine in Poland by introducing next-generation sequencing technology to common prenatal practice. Financial and other terms were not disclosed.

Warsaw, Poland-based Genomed was founded in 2008. According to its website, the firm has the widest genetic testing offering in the country.

The Scan

Comfort of Home

The Guardian reports that AstraZeneca is to run more clinical trials from people's homes with the aim of increasing participant diversity.

Keep Under Control

Genetic technologies are among the tools suggested to manage invasive species and feral animals in Australia, Newsweek says.

Just Make It

The New York Times writes that there is increased interest in applying gene synthesis to even more applications.

Nucleic Acids Research Papers on OncoDB, mBodyMap, Genomicus

In Nucleic Acids Research this week: database to analyze large cancer datasets, human body microbe database, and more.